uniQure
QURE
#5179
Rank
โ‚น137.68 B
Marketcap
โ‚น2,210
Share price
1.90%
Change (1 day)
49.02%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2025 (TTM): -โ‚น19.49 Billion

According to uniQure's latest financial reports the company's current earnings are โ‚น15.75 Million. In 2024 the company made an earning of -โ‚น21.28 Billion, an increase over its 2023 earnings that were of -โ‚น27.5 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น19.49 Billion-8.41%
2024 -โ‚น21.28 Billion-22.65%
2023 -โ‚น27.5 Billion139.01%
2022 -โ‚น11.51 Billion-138.54%
2021 โ‚น29.85 B-335.29%
2020 -โ‚น12.69 Billion13.88%
2019 -โ‚น11.15 Billion49.51%
2018 -โ‚น7.46 Billion4.55%
2017 -โ‚น7.13 Billion12.65%
2016 -โ‚น6.33 Billion-9.59%
2015 -โ‚น7 Billion66.95%
2014 -โ‚น4.2 Billion30.8%
2013 -โ‚น3.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น739.52 B-3,768.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น9.79 Billion-51.49%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-โ‚น17.93 Billion-11.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-โ‚น49.32 Billion 144.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น816.33 B-4,149.19%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
โ‚น60.93 B-402.24%๐Ÿ‡บ๐Ÿ‡ธ USA